Original Research
Accepted on 15 Aug 2025
European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd study
- 215 views
Original Research
Accepted on 15 Aug 2025
Case Report
Accepted on 15 Aug 2025
Original Research
Accepted on 15 Aug 2025
Original Research
Accepted on 15 Aug 2025
Original Research
Accepted on 15 Aug 2025
Review
Accepted on 15 Aug 2025
Systematic Review
Accepted on 15 Aug 2025
Review
Published on 15 Aug 2025
Review
Published on 15 Aug 2025
Correction
Published on 15 Aug 2025
Case Report
Published on 15 Aug 2025
Original Research
Published on 15 Aug 2025
Case Report
Published on 15 Aug 2025
Original Research
Published on 15 Aug 2025
Original Research
Published on 15 Aug 2025
Editorial
Published on 15 Aug 2025